Dr. Tapan Kadia, MD
Claim this profileM D Anderson Cancer Center
Expert in Adult T-Cell Leukemia/Lymphoma
Expert in Acute Myeloid Leukemia
24 reported clinical trials
37 drugs studied
About Tapan Kadia, MD
Education:
- Obtained MD from Baylor College of Medicine, Houston, Texas, in 2005.
- Completed Residency in Internal Medicine at The Johns Hopkins Hospital, Baltimore, Maryland (2005-2008).
- Undertook Fellowship in Hematology/Oncology at The University of Texas MD Anderson Cancer Center, Houston, Texas (2008-2011).
Experience:
- Currently serves as a Professor of Medicine and Chief of the Section of Leukemia at The University of Texas MD Anderson Cancer Center.
Area of expertise
1Adult T-Cell Leukemia/Lymphoma
Global LeaderHLA
prior malignancy
myelodysplastic syndrome
2Acute Myeloid Leukemia
Global LeaderHLA
prior malignancy
myelodysplastic syndrome
Affiliated Hospitals
Clinical Trials Tapan Kadia, MD is currently running
APG-2575 + Azacitidine
for Acute Myeloid Leukemia
This trial is testing a new drug (APG-2575) combined with an existing drug (Azacitidine) to treat certain blood cancers that have not responded to other treatments. The goal is to see if this combination can more effectively kill cancer cells.
Recruiting1 award Phase 1 & 23 criteria
Liposomal Daunorubicin-Cytarabine + Venetoclax
for Acute Myeloid Leukemia
This phase II trial studies how well liposome-encapsulated daunorubicin-cytarabine and venetoclax work in treating participants with acute myeloid leukemia that has come back (relapsed), does not respond to treatment (refractory), or has not been treated (untreated). Drugs used in chemotherapy, such as liposome-encapsulated daunorubicin-cytarabine and venetoclax, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting1 award Phase 2
More about Tapan Kadia, MD
Clinical Trial Related6 years of experience running clinical trials · Led 24 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Tapan Kadia, MD has experience with
- Venetoclax
- Decitabine
- Cladribine
- Cytarabine
- APG-2575
- Azacitidine
Breakdown of trials Tapan Kadia, MD has run
Adult T-Cell Leukemia/Lymphoma
Acute Myeloid Leukemia
Acute Myelogenous Leukemia
Myeloid Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Tapan Kadia, MD specialize in?
Is Tapan Kadia, MD currently recruiting for clinical trials?
Are there any treatments that Tapan Kadia, MD has studied deeply?
What is the best way to schedule an appointment with Tapan Kadia, MD?
What is the office address of Tapan Kadia, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.